BKD · available-data snapshot
Brookdale Senior Living Inc. (BKD): Available-Data Snapshot
TickerWorth does not publish a DCF fair value for Brookdale Senior Living Inc. (BKD); the reason is set out below. What its filings and market data do show is below. The snapshot also sets out its trading multiples against 5 peers. Snapshot as of Oct 19, 2026.
Model by Miraaj Patel · generated from public market data · Updated Oct 19, 2026 · How these pages are made
Why is there no fair value for BKD?
We do not publish a fair value for Brookdale Senior Living Inc.. What we can say from its filings and market data is below.
What is BKD's TickerWorth Score?
A weaker business than almost every company
Compared with Healthcare companies in US
Its strongest point: trades below our estimate of what it's worth. Its weakest: balance sheet looks stretched.
- Value · 56 of 100
Cheaper than 56% of Healthcare companies in US
- Price vs worth · 88 of 100
- Quality · 20 of 100
More profitable than 20% of Healthcare companies in US
- Financial health · 8 of 100
Financially stronger than 8% of Healthcare companies in US
- Growth · 10 of 100
Growing faster than 10% of Healthcare companies in US
- Momentum · 25 of 100
Outperformed 25% of Healthcare companies in US over the past year
Confidence: Medium confidence · Scored
Get the Undervalued Company of the Week.
- Price
- $9.96
- Market cap
- $2,
378, 619, 904 - 52-week high
- $17.09
- 52-week low
- $8.02
- Currency
- USD
- Exchange
- NYSE
Snapshot of Oct 19, 2026, quote time not published · Prices are delayed.
What we can say
We don't publish a discounted-cash-flow fair value for Brookdale Senior Living Inc. (BKD) because the free data sources we rely on don't expose the multi-year financials a DCF needs — common for small or thinly-covered listings. Rather than invent numbers, this page shows an honest snapshot of what the public data does support: the current price and size, any relative valuation multiples that exist, a book-value view, and a price-based read. Treat it as a descriptive starting point, not a valuation and not investment advice.
Read the full reasoning
On the numbers we do have, BKD trades at a recent price of $9.96, a market capitalisation of about $2,378,619,904, sitting 21% of the way up its 52-week range ($8.02–$17.09), on the NYSE.
The standard alternative to a DCF is relative valuation — comparing BKD's trading multiples against a sector benchmark. Here that gives Fwd P/E of 83.0× (richer than the peer median of 17.5×); P/S of 0.8× (cheaper than the peer median of 6.2×); EV/EBITDA of 16.2× (cheaper than the peer median of 18.5×). A cheaper multiple than peers can flag a discount or a market that expects weaker growth; it is a comparison, not a recommendation.
Finally, a price-based read — explicitly not a valuation. BKD is in a down-trend (price below both its 50- and 200-day averages), trading -41.7% from its 52-week high. Over the past year the stock is +15.1%. Moving-average trend and 52-week position describe where the stock has traded; they say nothing about what it is worth.
BKD vs peers
Sector benchmark (bellwethers, not direct competitors).
| Multiple | BKD | Peer median | Read |
|---|---|---|---|
| Fwd P/E | 83.0× | 17.5× | richer than |
| P/S | 0.8× | 6.2× | cheaper than |
| EV/EBITDA | 16.2× | 18.5× | cheaper than |
What does Brookdale Senior Living Inc. do?
What does it do?
Brookdale Senior Living Inc. owns, manages, and operates senior living communities in the United States. It operates in the Medical Care Facilities industry (Healthcare sector), headquartered in United States. The company employs roughly 22,440 people.
How does it make money?
The business turns $3.2B in annual revenue into profit. Out of every $100 of sales, about $7 is left as operating profit (operating margin of 6.8%), after a 28% gross margin on the products/services it sells. After all costs, taxes and interest, -4.7% of revenue becomes bottom-line net profit.
Is it financially healthy?
Financially it looks stretched: can just cover its short-term bills (1.1× current ratio), and is currently lossmaking.
Who at BKD filed insider trades?
| Date | Insider | Relationship | What happened | Value | Filing |
|---|---|---|---|---|---|
| Stengle Nikolas W | Director, Chief Executive Officer | Shares withheld (tax) | $225,379.30 | Form 4 for Stengle Nikolas W (opens sec.gov in a new tab) | |
| WINKLE C CHRISTIAN | Director | Grant / award | — | Form 4 for WINKLE C CHRISTIAN (opens sec.gov in a new tab) | |
| Asher Jordan R | Director | Gift | — | Form 4 for Asher Jordan R (opens sec.gov in a new tab) | |
| White Chad C. | EVP, General Counsel & Sec'y | Gift | — | Form 4 for White Chad C. (opens sec.gov in a new tab) | |
| Pritchett Jaclyn C | EVP - Human Resources | Shares withheld (tax) | $61,842.60 | Form 4 for Pritchett Jaclyn C (opens sec.gov in a new tab) | |
| Pritchett Jaclyn C | EVP - Human Resources | Shares withheld (tax) | $226,914.30 | Form 4 for Pritchett Jaclyn C (opens sec.gov in a new tab) |
A disclosure, not a signal to trade. Source: SEC EDGAR (Form 4). Older filings and the 90-day buying-and-selling read are part of Pro. See plans
Companies we do put a number on
Not investment advice. TickerWorth Score is a model output.
A descriptive, available-data snapshot and relative comparison — NOT a DCF, NOT a price target, and NOT investment advice. TickerWorth is not a licensed investment adviser, and these figures are estimates from public market data that can be wrong, stale or incomplete.